Information Provided By: 
Fly News Breaks for August 22, 2019
SPLK
Aug 22, 2019 | 08:07 EDT
Wedbush analyst Steve Koenig lowered his price target for Splunk to $153 from $158 on lower near-term cash flows. Nonetheless, the analyst reiterates an Outperform rating on the shares after the company delivered a "solid" beat and raise, with "impressive results" on most major metrics.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
